日本食品微生物学会雑誌
短報
プロバイオティック乳酸菌Enterococcus faecalis FK-23の薬剤感受性とバンコマイシン耐性遺伝子の確認
林 篤志北村 良久嶋田 貴志
著者情報
ジャーナル フリー

27 巻 (2010) 4 号 p. 196-199

詳細
PDFをダウンロード (705K) 発行機関連絡先
抄録

Enterococcus faecalis FK-23, isolated from human intestinal tract, was used widely as probiotics. However, vancomycin-resistant Enterococci (VRE) containing vancomycin-resistant E. faecalis also exist, and appearing of VRE has serious problems in the world. In this study, we investigated antimicrobial susceptibility of E. faecalis FK-23 and vancomycin resistance genes prevalence in the organisms. E. faecalis FK-23 was susceptible to various antibiotics such as benzylpenicillin, aminobenzylpenicillin, gentamicin, erythromycin, minocyclin, levofloxacin and vancomycin, and showed intermediate resistance to cefazolin and ciprofloxacin by Kirby-Bauer disk method. Minimal inhibitory concentration (MIC) of vancomycin to E. faecalis FK-23 showed 2 μg/ml by using agar dilution method. Vancomycin resistance genes, such as vanA, vanB, vanC-1, vanC-2, and vanC-3 were not detected in E. faecalis FK-23 by using PCR method. These results suggest that E. faecalis FK-23 is safety for using probiotics.

著者関連情報
© 2010 日本食品微生物学会
前の記事 次の記事

閲覧履歴
前身誌

食品と微生物

feedback
Top